Ascension Health's Federal Lobbying Record
Ascension Health's $7.1M in disclosed federal lobbying puts it in the mid-tier of registered filers. Spending in the seven-figure range is common for established trade groups, mid-size corporations, and advocacy organizations that maintain a steady but not aggressive presence on Capitol Hill.
Across the 5-year window from 2020 to 2024, Ascension Health's annual disclosed lobbying spend has held roughly steady — $1.5M at the start versus $1.6M at the most recent year-end. Year-to-year wobbles inside that range usually reflect timing of legislative cycles rather than a strategic shift.
Ascension Health's disclosed lobbying covers 5 general issue areas — a moderate footprint. Filers in this range tend to engage on a coherent cluster of related topics rather than spreading effort across the federal agenda.
1 of 5 lobbyists reported by Ascension Health (20%) disclose prior federal government service — a small minority of the named bench.
Among the named bench, lobbyists with disclosed prior federal service include Kenneth L. Lewis (Former Director of Policy, Department of Energy). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.
Within the Healthcare sector, Ascension Health ranks #11 of 24 tracked organizations by disclosed lobbying spend. The sector leader is American Hospital Association at $128.0M; the sector average is $16.4M. Ascension Health's $7.1M sits 56% below the sector average.
Ascension Health's LobbySpend Influence Score of 52/100 (grade C) is the most common grade in the index — it covers organizations with established but moderate federal advocacy programs. The score combines disclosed total spend (40%), issue breadth (30%), and revolving-door connections (30%). A C-grade is typical of mid-size corporations and trade associations with steady quarterly filings on a focused issue set.
Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.
Track Ascension Health's lobbying filings
Subscribe for LobbySpend updates by email. No spam, unsubscribe anytime.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2024 Oct-Dec | Tarplin, Downs & Young | TAXMMMGOV+1 | 3 | $469K |
| 2024 Jul-Sep | Covington & Burling | GOVHCRMMM+1 | 2 | $330K |
| 2024 Apr-Jun | Invariant LLC | HCRMEDGOV+1 | 2 | $407K |
| 2024 Jan-Mar | Subject Matter | MMMHCR | 3 | $394K |
| 2023 Oct-Dec | Steptoe & Johnson | TAXHCR | 1 | $419K |
| 2023 Jul-Sep | Williams & Jensen | TAXMMM | 2 | $322K |
| 2023 Apr-Jun | Mehlman Consulting | HCRMEDGOV | 1 | $381K |
| 2023 Jan-Mar | Franklin Square Group | MEDMMMHCR | 4 | $345K |
Ascension Health Lobbying FAQ
Ascension Health has spent $7.1M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.
Ascension Health lobbies on 5 policy issues, including Health Issues, Medicare/Medicaid, Medical/Disease Research, Taxation. These disclosures are filed quarterly with the Senate Office of Public Records.
Ascension Health has an Influence Score of 52/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).
Ascension Health employs 5 registered lobbyists, of whom 1 have revolving door connections, meaning they previously held government positions before becoming lobbyists.
Ascension Health has contacted 8 government entities as part of their lobbying activities, including Dept of Commerce, Dept of Health & Human Services, Dept of Transportation.
Explore Other Lobbying Organizations
$387.8M lobbying spend · Trade Association · Influence Score B
$348.2M lobbying spend · Real Estate · Influence Score B
$135.8M lobbying spend · Pharmaceutical & Health Products · Influence Score B
$128.0M lobbying spend · Healthcare · Influence Score B
Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.